Douglas Manufacturing
New Zealand Updated 9 July 2026
Douglas Manufacturing is a finished-dose manufacturer based in New Zealand. It appears in 20 regulatory filings across 4 regulators, without an active US DMF or CEP on file. Its filings concentrate with EDE (AE), NPRA (MY) and SFDA (Saudi Arabia). Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 30 May 2025 as VAI.
2
registered plants
1 with an FDA FEI number
20
filings
across 4 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
6 of 6 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 30 May 2025 VAI US FDA
- 11 October 2019 VAI US FDA
- 1 December 2017 VAI US FDA
- 29 July 2016 NAI US FDA
- 4 July 2014 VAI US FDA
- 31 May 2011 NAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Auckland, United Arab Emirates | Not on file |
| New Zealand, New Zealand | 3005641565 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| EDE (AE) | 12 | None |
| NPRA (MY) | 4 | None |
| SFDA (Saudi Arabia) | 3 | None |
| MINSA (CR) | 1 | None |
| US FDA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Douglas Manufacturing comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 30 May 2025.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates